Holman RR - Search Results

1

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC; 4-T Study Group. Holman RR, et al. N Engl J Med. 2007 Oct 25;357(17):1716-30. doi: 10.1056/NEJMoa075392. Epub 2007 Sep 21. N Engl J Med. 2007. PMID: 17890232 Free article. Clinical Trial.

2

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

Holman RR, Steemson J, Turner RC. Holman RR, et al. Diabet Med. 1987 Sep-Oct;4(5):457-62. doi: 10.1111/j.1464-5491.1987.tb00909.x. Diabet Med. 1987. PMID: 2959438 Clinical Trial.

3

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results].

Levy JC, Cull CA, Stratton IM, Holman RR, Turner RC. Levy JC, et al. Among authors: holman rr. Journ Annu Diabetol Hotel Dieu. 1993:123-37. Journ Annu Diabetol Hotel Dieu. 1993. PMID: 8331860 Clinical Trial. French. No abstract available.

4

Lessons from UK prospective diabetes study.

Turner RC, Holman RR. Turner RC, et al. Among authors: holman rr. Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S151-7. doi: 10.1016/0168-8227(95)01105-m. Diabetes Res Clin Pract. 1995. PMID: 8529508 Review.

5

Insulin therapy in type II diabetes.

Holman RR, Turner RC. Holman RR, et al. Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S179-84. doi: 10.1016/0168-8227(95)01077-q. Diabetes Res Clin Pract. 1995. PMID: 8529512 Review.

6

The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group.

Turner RC, Holman RR. Turner RC, et al. Among authors: holman rr. Ann Med. 1996 Oct;28(5):439-44. doi: 10.3109/07853899608999105. Ann Med. 1996. PMID: 8949976 Free article. Clinical Trial.

7

The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.

Hammersley MS, Meyer LC, Morris RJ, Manley SE, Turner RC, Holman RR. Hammersley MS, et al. Among authors: holman rr. Metabolism. 1997 Dec;46(12 Suppl 1):44-9. doi: 10.1016/s0026-0495(97)90317-6. Metabolism. 1997. PMID: 9439559 Clinical Trial.

8

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC. Rachman J, et al. Among authors: holman rr. Diabetes Care. 1998 May;21(5):810-6. doi: 10.2337/diacare.21.5.810. Diabetes Care. 1998. PMID: 9589246 Clinical Trial.

9

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Turner RC, Cull CA, Frighi V, Holman RR. Turner RC, et al. Among authors: holman rr. JAMA. 1999 Jun 2;281(21):2005-12. doi: 10.1001/jama.281.21.2005. JAMA. 1999. PMID: 10359389 Clinical Trial.

10

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.

Manley SE, Stratton IM, Cull CA, Frighi V, Eeley EA, Matthews DR, Holman RR, Turner RC, Neil HA; United Kingdom Prospective Diabets Study Group. Manley SE, et al. Among authors: holman rr. Diabet Med. 2000 Jul;17(7):518-23. doi: 10.1046/j.1464-5491.2000.00320.x. Diabet Med. 2000. PMID: 10972581 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters